Economy

Sustainable soy: when collaborating to protect the Amazon backfires

a soy field stands next to a fragment of the Amazon forest at the region of Cipoal in Santarem, Para state, Brazil.

This content was published on Feb 12, 2026 Commodity firms working together to source deforestation-free soy in Brazil are being investigated under anti-cartel laws. They also risk losing tax benefits due to pressure from powerful farming lobbies.

Opinion

Agribusiness

Governments and industry must work across the cocoa and gold sector to address child labour

This content was published on Feb 12, 2026 Eliminating child labour in one sector risks merely displacing it into another unless complex social and economic systems are addressed comprehensively.

Agribusiness

When Swiss food start-ups fail

This content was published on Feb 11, 2026 Switzerland promotes itself as a global hub for food technology and innovation, but it is not always easy for start-ups to gain a foothold.

Novartis: new global biomedical research centre opens in San Diego

Pharma supply chains

Novartis begins construction of new research centre in San Diego, US

This content was published on Feb 9, 2026 Novartis has begun work on a new global biomedical research centre in San Diego, United States. The 43,300 m2 facility will be operational in 2029 and house around 1,000 employees.

Medicines: sales increase by 5% in Switzerland in 2025

Drug pricing

Swiss medicine revenues pegged back by price reductions

This content was published on Feb 7, 2026 Swiss pharma market records CHF8.1 billion revenues at factory prices in 2025.

New treatments

Science podcast: the story behind the ‘longevity pill’ rapamycin

This content was published on Feb 6, 2026 In episode 5 of this season's Swiss Connection science podcast, we talk about the discovery of TOR and its potential for longevity.

Medicine access

First Alzheimer’s drug authorised in Switzerland

This content was published on Feb 4, 2026 Swissmedic authorises first drug to slow down the progression of Alzheimer's disease.

Healthcare innovation

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

This content was published on Jan 31, 2026 Weleda CEO Tina Müller talks about the quiet revolution she initiated at the Swiss cosmetics and healthcare company.

AI and medicine

How AI is used in diagnostics

This content was published on Jan 30, 2026 Medical experts now use artificial intelligence to help them diagnose and monitor diseases. But does this mean AI will replace doctors?

AI and medicine

From London to Lausanne: how Isomorphic Labs is rewriting drug discovery

This content was published on Jan 30, 2026 Google DeepMind spin-off Isomorphic Labs is expanding in Switzerland to achieve its ambitious goal to "solve all diseases" with AI.

Page 9 of 36

First … 7 8 9 10 11 … Last

Economy

Popular Stories

Most Discussed

Economy

More

Sustainable soy: when collaborating to protect the Amazon backfires

More

Governments and industry must work across the cocoa and gold sector to address child labour

More

When Swiss food start-ups fail

More

Novartis begins construction of new research centre in San Diego, US

More

Swiss medicine revenues pegged back by price reductions

More

Science podcast: the story behind the ‘longevity pill’ rapamycin

More

First Alzheimer’s drug authorised in Switzerland

More

Going global: Weleda’s new CEO wants to put the cosmetics company on the map

More

How AI is used in diagnostics

More

From London to Lausanne: how Isomorphic Labs is rewriting drug discovery

Popular Stories

Most Discussed